Article
Cyclooxygenase-1 haplotype modulates platelet response to aspirin.
Journal of thrombosis and haemostasis : JTH - 1 Oct 2005
Maree A O, Curtin R J, Chubb A, Dolan C, Cox D, O'Brien J, Crean P, Shields D C, Fitzgerald D J
Abstract excerpt
BACKGROUND: Aspirin (acetylsalicylic acid) irreversibly inhibits platelet cyclooxygenase (COX)-1, the enzyme that converts arachidonic acid (AA) to the potent platelet agonist thromboxane (TX) A2. Despite clear benefit from aspirin in patients with cardiovascular disease (CAD), evidence of heterogeneity in the way individuals respond has given rise to the concept of 'aspirin resistance.' AIMS: To evaluate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
